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Abstract 
Background: In today’s knowledge rich environment even the largest organisations, such as pharma-
ceutical or medical technology companies, realize a bottleneck of knowledge resources for innovation. 
Harnessing the innovation potential of patients and other healthcare consumers contends to be part of 
the solution.  
Objective: This paper questions if online health platforms can support innovative activities by creating 
and transferring relevant knowledge from engaged healthcare consumers towards innovating 
healthcare companies. It aims at identifying online health platforms that can serve as innovation in-
termediaries. 
Method: An exploratory, case-study-based approach is chosen. Through desk review a sample of 
online health platforms is created and case vignettes are developed. Content analysis returns descrip-
tive attributes which are examined throughout the sample. 
Findings: 30 out of 306 health-related online platforms qualify as innovation intermediary. We ob-
serve that online innovation intermediaries look for profound experience from healthcare consumers, 
in particular patients with a higher degree of affectedness. Further qualitative findings are presented. 
Conclusion: This paper puts emphasis on the mediating role of selected online health platforms as 
advocates of innovation. It suggests a classification and description of the variety of “health 2.0” plat-
forms and sketches a preliminary picture of the market for online innovation intermediaries in 
healthcare today. 
 
Keywords: Innovation intermediaries, Open innovation, Healthcare, Health 2.0, Classification. 
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1 Introduction 
In today’s healthcare systems, rising demand and expectations are increasingly out of step with the 
funding models available. In 2010, health spending in EU member states consumed on unweighted 
average 9.0% of their GDP while annual growth in health spending more than doubled GDP growth 
over the past decade (OECD, 2012). Without radical change it seems unlikely that we can sustain the 
kind of healthcare which we associate with highly developed societies. The healthcare sector has con-
tinuously been characterised by innovation – in treatments and drugs, in hospital and care systems, in 
primary and acute care pathways and in chronic disease management. Innovation has habitually been a 
collaborative, multi-player activity. But in today’s knowledge rich environment even the largest organ-
isations, such as pharmaceutical or medical technology companies, realize a bottleneck of knowledge 
resources. This drives a search to engage and employ a wide range of additional players. The ideas 
behind "open innovation" essentially involve finding ways to spread the knowledge net much more 
widely, bringing into the company’s innovation process a wider range of players and mobilising their 
experience and creativity in the search for novel and sustainable solutions (Chesbrough, 2003). 
One key direction in which healthcare innovation can open up lies in harnessing the innovation poten-
tial of patients and their carers (Wanless, 2002; Røtnes and Staalesen, 2009; Boote et al., 2002; Pater-
son, 2004). There are many examples where patients have played a key role in developing solutions to 
their healthcare challenges – and there is evidence that this process is accelerating (Habicht et al., 
2012). One powerful route is opened up via interactive online platforms which build and mobilise 
communities with common interests. Surprisingly, given recent trends and challenges in the areas of 
healthcare, several scholars state that there is insufficient research on the impact of web 2.0 in 
healthcare (Randeree, 2009; Leimeister et al., 2008; Boulos and Wheeler, 2007). Leimeister et al. 
(2008) add that online healthcare communities are receiving increased research attention as new spe-
cial interest groups, but much is still unknown about the design and impact of these groups.  
This paper aims to link the domains of web 2.0 in healthcare and open innovation. We perform an ex-
tended review of such “health 2.0” platforms and examine if they can serve as innovation intermediar-
ies. Our special interest lies in identifying health 2.0 platform operators who, on the one hand, make 
use of the innovation potential (i.e. the knowledge, experience, and ideas) of healthcare consumers and 
professional stakeholders and, on the other hand, can fulfil a bridging role between health 2.0 users 
and pharmaceutical/medical companies. These companies eventually have the resources to produce 
and commercialise a novel product. Therefore, our research question formulates as: How can online 
innovation intermediaries be identified in the domain of “health 2.0”? 
The remainder of the paper is organized as follows. First, we introduce the background on web 2.0 in 
healthcare and online communities as well as the role of intermediaries in the innovation process. 
These pieces are synthesized into a typology on health 2.0 platforms. Section three explains our ex-
plorative approach based on a case study design. Then, we present an in-depth analysis of the case 
sample which is completed by a discussion of findings (sections four and five). Study limitations, op-
tions for future research, and a conclusion close the paper (sections six and seven). 
2 Setting the Scene 
2.1 Web 2.0 and online communities in healthcare 
The term web 2.0 commonly refers to online platforms that enable increased information exchange 
between lay users, social networking and collective knowledge production (Adams, 2010; O´Reilly, 
2005). As available definitions are not congruent, Adams (2010) pinpoints the following common 
points: (1) in web 2.0, lay users are important producers of content; (2) users interact with themselves 
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or the online platform; (3) facilitation of social opportunities such as community building and collabo-
ration. As a discipline-related adaptation that incorporates the use of web-based technology in 
healthcare, the terms health 2.0 or medicine 2.0 were coined (Hughes et al., 2008; Eysenbach, 2008). 
In a similar vein, Van de Belt et al. (2010) have done a review on available definitions concluding by 
the following characteristic themes: (1) web 2.0 is the underlying means for communication and in-
formation sharing; (2) increased participation of healthcare consumers; (3) increased participation of 
health professionals or other stakeholders such as  payers, providers, researchers; (4) emergence of 
online communities and social networking; (5) improving collaboration between health consumers and 
professionals; (6) health information that is patient-driven and user-generated; and (7) positive impact 
on the healthcare system in terms of higher quality and efficiency. A multitude of websites that at-
tempt to incorporate (parts of) the above aspects have emerged in recent years – we will call them 
health 2.0 platforms from here on. A small number of prior studies has already reviewed and classified 
the landscape of health 2.0 platforms (Weber-Jahnke et al., 2011; Goerlitz et al., 2010; Kuehne et al., 
2011; Birnsteel et al., 2008). However, the potential of web 2.0 in healthcare towards open, collabora-
tive innovation remains under-researched in these works.  
Virtual and online communities are one of the more popular forms of user interaction in the web 2.0 
(Romm et al. 1997; Correia et al. 2010; Kuehne et al. 2011; Leimeister et al. 2008). In online health 
communities, users not only provide each other with experiences and (sometimes emotional) support, 
they also enable one another to comprehend the necessary medical information and science in the con-
text of the respective disorder (Frost and Massagli, 2008; Hoch and Ferguson, 2005). Such communi-
ties are characterized by a high degree of interaction between users, and reciprocal exchange of infor-
mation. The emergence of these interactive capabilities enable online health communities to be an ef-
fective source of jointly constructed and shared knowledge through participation of healthcare con-
sumers, professionals and other stakeholders. 
2.2 The role of intermediaries in the innovation process 
Different strands of research elaborate on the importance of external sources of knowledge for enhanc-
ing firms’ capability to innovate, e.g. research on technological change (Rosenberg, 1982), collective 
invention (Allen, 1983), user innovation (Von Hippel, 1988), and open innovation (Chesbrough, 
2003). To facilitate these knowledge inflows, a large number of firms emerged in the last decade 
which serve as intermediaries in an open innovation process. A rich literature describes and analyses 
the role of intermediaries as third parties mediating between manufacturing firms and their customers 
(see review by Howells, 2006). From a network perspective, intermediaries connect an actor (the 
manufacturing firm) with different sources of knowledge and ideas (e.g. their customers) (Diener and 
Piller, 2010). Adapted to the context of this paper, ‘manufacturing firms’ indicate pharmaceutical or 
medical technology companies. Howells (2006:720) defines an innovation intermediary as follows: 
“An organization or body that acts as an agent or broker in any aspect of the innovation process be-
tween two or more parties. Such intermediary activities include: helping to provide information about 
potential collaborators; brokering a transaction between two or more parties; acting as a mediator, 
or go-between, bodies or organizations that are already collaborating; and helping find advice, fund-
ing and support for the innovation outcomes of such collaborations”.  
In the virtual world, a number of online innovation intermediaries have emerged who leverage the In-
ternet to support the innovation capacity of manufacturing firms. Compared to the competences of in-
novation intermediaries in the physical world, they are significantly extended in virtual environments 
with regard to network access, knowledge absorption, knowledge integration, and knowledge imple-
mentation (Verona et al., 2006). Also within healthcare, health 2.0 platforms can act as online innova-
tion intermediaries when bridging the gap between the online crowd of healthcare consumers and 
medical manufacturing firms. Such firms can greatly benefit from online innovation intermediaries for 
two reasons (Verona et al., 2006). First, they help to augment the network access by enhancing the 
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reach in engaging with customers. Second, firms can gain richness through bidirectional interactions 
and higher quality of its content.  
2.3 Typology of health 2.0 platforms 
In order to classify the multitude of available health platforms, we want to synthesize the above into a 
conceptual classification for health 2.0 platforms and propose the following dimensions: (i) the quali-
fication as an innovation intermediary and (ii) the availability of an online community for its users. 
Both dimensions are defined as Boolean values (yes or no). We take these dimensions as basis for a 
two by two typology; further reasoning for both dimensions is given next. 
We surmise that some health 2.0 platforms can fulfil the role of an online innovation intermediary un-
der certain circumstances. Verona et al. (2006) describes the key roles as to collect dispersed sources 
of knowledge, to recombine it to support innovation, and to transfer it to new contexts (i.e. manufac-
turing firms). For the purpose of this paper, we therefore assess two essential attributes. When both of 
the attributes are fulfilled, we consider a health 2.0 platform suitable as innovation intermediary. 
• Explicit enquiry towards the users: The health 2.0 platform has a determined interest in gathering 
data, information or knowledge from its users. Hence, the users are explicitly asked to share their 
health data, treatment experiences, unmet needs, preferences, opinions, etc. From the intermedi-
ary’s view, the user is regarded as a valuable source of knowledge. 
• Knowledge exploitation: Once users’ knowledge is collected, the platform operator should exploit 
it somehow. One possible option is that the data could be analysed and aggregated into some new 
form by the intermediary himself. Another option, from the perspective of the innovation process, 
is that the newly gathered knowledge is being transferred to an innovating firm for the research and 
development of new products. 
The second differentiation stresses the community dimension which we measure by the presence or 
absence of an online community for platform users. Online communities with all its social and behav-
ioural aspects attached can have a significant impact in innovation outcomes (Fueller et al., 2004; 
Franke and Shah, 2003). Platform concepts that do not stem from group dynamics are, for instance, 
idea contests, where users submit a problem solution, or survey-like enquiries, where users are being 
asked for their opinion or experience. This differentiation is important as it requires a different set of 
methods and skills from the innovation intermediary.  
3 Method 
Since online innovation intermediaries in healthcare, as defined in this paper, are a rather new phe-
nomenon, we chose an explorative qualitative research approach based on a multiple-holistic case 
study design (Yin, 2003). Data collection and analysis follow five steps as clarified next. 
I. Sample collection: First, we created a sample of health or medicine-related online platforms through 
desk research. Unlike similar studies (Goerlitz et al., 2010; Weber-Jahnke et al., 2011), we did not 
employ a keyword-based web search to find relevant platforms, but built on the following key sources: 
• An initial sample was populated by platforms showcased at three leading conference series in the 
field. We assume that operators of especially successful, innovative, or recent platforms would 
speak up there. For the period 2007 till end of 2012, agendas and speaker affiliations were screened 
from 19 “Health 2.0” (www.health2con.com), 5 “Medicine 2.0” (www.medicine20congress.com) 
and 2 “Doctors 2.0 & You” (www.doctors20.com) conferences.  
 In addition, we enlarged the sample by screening scientific and practitioner-oriented articles (Bou-
los and Wheeler, 2007; Hartmann et al., 2011; Frost and Massagli, 2008; Bullinger et al., 2012; 
Leimeister and Krcmar, 2005; Swan, 2009; Randeree, 2009; Goerlitz et al., 2010; Weber-Jahnke et 
al., 2011; Seeman, 2008; Allison, 2009; Dannecker and Lechner, 2007; Pharma Relations, 2010; 
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Birnsteel et al., 2008; Miller and Washington, 2012). The identified references originate from a 
search using “health 2.0” and “web 2.0 +healthcare” as search terms in Google Scholar. 
For the purpose of this study, we focus on platforms that offer knowledge or instruments to advance 
the user’s desire for better health. The user should directly benefit from using the platform, e.g. 
through gaining new health knowledge, exchanging with peers or as a source of support, or should 
have the opportunity to contribute his knowledge and experience. Therefore, we excluded (i) pure cor-
porate representations of companies or associations, and (ii) platforms that already stopped operations 
by Dec 2012. The goal of the selection process was to create a not necessarily complete, but broad 
repository of health platforms available. 
II. Development of case vignettes: By exploring each of the websites of the sample following the 
method of “third-party web assessment” (Irani & Love, 2008), we developed a structured case vignette 
for each platform – available in a central repository in Microsoft Excel. 
III. Removal of cases without user involvement: In order to ensure the interactive “2.0” character of the 
health platforms, we screened the vignettes and retained only those cases that offer a minimum level 
of user involvement, i.e. allow users to create, add or share content. For instance, pure health infor-
mation portals were removed through this step. 
IV. Qualitative content analysis: Following the procedure of content analysis (Mayring, 2000), further 
dimensions of analysis that oriented along the themes of health 2.0 (cf. section two) were elicited in 
multiple iterative rounds until saturation was reached. 
V. Application of new dimensions to the sample: The last step covered a coding process based on the 
new dimensions identified in step 4. Two researchers from our team independently assessed each of 
the health 2.0 platforms according to the criteria (Mayring, 2000). Anchor examples were chosen. 
4 Findings 
4.1 Description of the health 2.0 sample 
The sample collection yielded 306 health- or medicine-related online platforms (step I) of which 183 
are health 2.0 platforms with user involvement (step III). This sub-sample will be the basis for the fol-
lowing analyses. Figure 1 shows the distribution of cases according to the above defined typology. For 
your reference, find the complete repository online at http://tinyurl.com/clx2ped. 
Qualification as
innovation 
intermediary
Availability of online community
Health 2.0 
platforms
No Yes
No
Ye
s 14
(8%)
45
(25%)
16
(9%)
108
(59%)
∑ 183
 
Figure 1. Empirically populated typology of health 2.0 platforms (Number of cases found) 
For illustration, we present selected examples in the following. A representative case for a community 
based online innovation intermediary is InnovationByYou (www.innovationbyyou.com). It is an online 
platform sponsored by Coloplast, a manufacturer of medical devices and services related to ostomy, 
urology, continence and wound care. At InnovationByYou, like-minded patients with ostomy or con-
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tinence issues can share ideas and learn from each other. The platform operator organizes idea chal-
lenges on related topics. Promising solution proposals are developed by the community members until 
prototype stage and are then presented to the top management to decide on large-scale production. 
Further examples of this type are PatientsCreate.com, HealthUnlocked.com, CancerCommons.org, 
Ambulanzpartner.de, Doctors.net.uk and others. Full details are given in the online repository. 
A promising case as non-community based innovation intermediary is the Data Design Diabetes Inno-
vation Challenge (www.datadesigndiabetes.com) initiated by Sanofi, a French pharma. Entrepreneurs, 
scientists or designers, as individuals or teams, are called to submit their solution proposals on diabe-
tes-related problems. The platform creates its attraction from prize money, a board of judges and a 
competitive atmosphere. Strongest ideas receive mentorship by Sanofi. Other examples of this type are 
Connecting-Nurses.com, HealthTechHatch.com, iWantGreatCare.org, ArmyOfWomen.org and others. 
4.2 In-depth identification of innovation intermediaries in health 2.0 
Content analysis of the case vignettes provided further dimensions which describe crucial aspects of 
online innovation intermediaries. Table 1 lists the dimensions, related key questions and their possible 
answer values. Details on these dimensions and their empirical occurrence are presented in the re-
mainder of this section while table 2 shows all findings in figures. 
Involvement of healthcare consumers and professional stakeholders: To gain a deeper understanding 
of who the user actually is, we screened the sample for user types. On the top level, we suggest distin-
guishing between healthcare consumers and healthcare professionals. Healthcare consumers can be 
distinguished by the level of their affectedness into three general categories: (1) consumers who are 
well, (2) those who are newly diagnosed with an illness, and (3) those who are chronically ill including 
their medical caregivers (Cain et al., 2000). Concerning the involvement of professional stakeholders 
in healthcare, we found empirical evidence for the following two subgroups: (1) Providers, e.g., doc-
tors, nurses, other health professionals and medical experts who provide care in hospitals, doctor’s 
surgeries, nursing homes, and others; (2) Suppliers, e.g., scientific institutions and research groups, 
pharmaceutical and medical technology companies, who develop new products and treatments and 
heavily invest in research and development; pharmacies and wholesalers, who mostly do resale. 
Analysing the data sample reveals that the big majority (83%, 152#) of health 2.0 platforms address 
healthcare consumers as user group while almost half of the platforms (45%, 82#) enable healthcare 
professionals to get involved. Looking specifically at consumer segmentation of the innovation inter-
mediaries, we find that each intermediary with consumer involvement does address the chronically ill 
Dimension Question Answer choice* and answer attributes 
Healthcare 
consumer 
involvement 
Is the platform designed 
to involve consumers? If 
yes, which type? 
mv No The well The newly  diagnosed 
Chronically 
ill and their 
caregivers 
  
Healthcare 
professional 
involvement 
Is the platform designed 
to involve professionals? 
If yes, which type? 
mv No Providers Suppliers   
Level of 
interaction 
Which level of interac-
tion can be attained by 
the users? 
sv Information Communica-tion Consultation Cooperation Collaboration 
Stage of 
innovation 
process 
At which stage of the 
innovation process the 
users' input can be uti-
lized? 
mv None Fuzzy Front End 
New Product 
Development    
Online 
community 
(availability 
& access) 
Does the platform offer 
an online community to 
its users? If yes, are there 
access restrictions? 
sv No Non-restricted Restricted     
* sv = single value only, mv = multiple values possible 
Table 1. Elicited dimensions 
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as part of their target user group. In combination with newly diagnosed consumers, these two sub-
groups bring along a certain level of experience and knowledge about particular disorders. In contrast 
to this, the service and content offerings of non-intermediary health platforms are more often designed 
to meet the demands of the well consumers. 
Regarding the professional involvement, innovation intermediaries in health 2.0 are more open to in-
tegrate healthcare professionals than non-intermediary platforms. The relative shares of professional 
involvement are 73% for the intermediaries versus 39% for the non-intermediaries. Also, the interme-
diaries target a wider professional audience, notably providers and suppliers, while the non-
intermediaries mostly focus on providers. In summary, we observe that innovation intermediaries in 
health 2.0 are seemingly interested in a broad user group (consumers and professionals) that provides a 
rich base of knowledge and experience. 
Level of interaction: The level of interaction refers to the structure of the underlying relationships be-
tween the initiating health platform and its users. We propose five levels of interaction, in order of in-
creasing intensity of interaction. (1) Information: The first level of interaction serves the purpose of an 
informational exchange. It can be characterized by a unilateral relationship between the platform and 
one user at a time. (2) Communication: The next level of interaction refers to a two-way exchange 
within a virtual community. The members are motivated by personal benefits and each individual’s 
interest in an overarching topic which is also shared by the rest of the community. On behalf of the 
platform and community operator, the members’ exchange is not tied to a common, innovation-related 
goal and requires little coordination efforts only, i.e. the community is highly self-governing. Online 
discussion boards, support groups and forums are examples in this category. (3) Consultation: It de-
scribes a deliberate enquiry regarding a specific question towards the healthcare consumers or other 
Absolute figures Relative figures
Dimension Attribute N Y N Y N Y Total N Y N Y N Y Total
Subtotal 45 108 14 16 153 30 183 100% 100% 100% 100% 100% 100% 100%
Consumer None 2 22 3 4 24 7 31 4% 20% 21% 25% 16% 23% 17%
Involvement W* 5 10 0 0 15 0 15 11% 9% 0% 0% 10% 0% 8%
W-ND* 10 21 0 0 31 0 31 22% 19% 0% 0% 20% 0% 17%
W-ND-CI* 17 4 8 2 21 10 31 38% 4% 57% 13% 14% 33% 17%
ND-CI 9 31 2 6 40 8 48 20% 29% 14% 38% 26% 27% 26%
CI 2 20 1 4 22 5 27 4% 19% 7% 25% 14% 17% 15%
Professional None 29 64 5 3 93 8 101 64% 59% 36% 19% 61% 27% 55%
Involvement Provider 15 35 1 0 50 1 51 33% 32% 7% 0% 33% 3% 28%
Prov-Supp 1 9 7 11 10 18 28 2% 8% 50% 69% 7% 60% 15%
Supplier 0 0 1 2 0 3 3 0% 0% 7% 13% 0% 10% 2%
Level of Information 23 0 0 0 23 0 23 51% 0% 0% 0% 15% 0% 13%
Interaction Communication 2 101 0 2 103 2 105 4% 94% 0% 13% 67% 7% 57%
Consultation 13 1 13 2 14 15 29 29% 1% 93% 13% 9% 50% 16%
Cooperation 7 6 1 4 13 5 18 16% 6% 7% 25% 8% 17% 10%
Collaboration 0 0 0 8 0 8 8 0% 0% 0% 50% 0% 27% 4%
Stage of None 45 108 3 2 153 5 158 100% 100% 21% 13% 100% 17% 86%
Innovation FFE** 0 0 10 9 0 19 19 0% 0% 71% 56% 0% 63% 10%
Process FFE-NPD** 0 0 0 5 0 5 5 0% 0% 0% 31% 0% 17% 3%
NPD** 0 0 1 0 0 1 1 0% 0% 7% 0% 0% 3% 1%
Community None 45 0 14 0 45 14 59 100% 0% 100% 0% 29% 47% 32%
Access Non-restricted 0 92 0 10 92 10 102 0% 85% 0% 63% 60% 33% 56%
Restricted 0 16 0 6 16 6 22 0% 15% 0% 38% 10% 20% 12%
* W - Well consumers; ND - Newly diagnosed consumers; CI - Chronically ill consumers incl. their caregivers
** FFE - Fuzzy Front End; NPD - New Product Development
Community Community Subtotal Community Community Subtotal
Innovation Intermediary Innovation 
Intermediary
Innovation Intermediary Innovation 
IntermediaryN Y N Y
 
Table 2. Descriptive statistics on the sample of health 2.0 platforms  
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users. Hence, the interaction is based on a dyadic relationship. Consumers are asked about their per-
spectives, needs, or priorities. Among others, appraisal platforms and innovation contests are usually 
settled in this category. (4) Cooperation: When online communities start to develop a momentum on 
its own, we can find a community-based relationship between the platform and a network of users. 
Basically there are n:n relationships between the members in the community and 1:n relationships be-
tween the platform operator and the members. Cooperation in this context is characterized by partner-
ships between users themselves and the platform operator. They work together for a common goal on 
an irregular and little formalized basis in order to bring a joint topic or project forward. (5) Collabora-
tion: Collaboration can be considered as a more intense form of cooperation. On a regular basis, users 
work closely together in well-defined team structures. They share a common goal for the advancement 
of a joint project. Typically, the degree of coordination by the platform operator increases.  
When we look into the empirical data again, it becomes apparent that the levels of interactions differ 
greatly between the four types of the typology. For example, when we look at non-intermediary plat-
forms without communities, the levels ‘information’ and ‘consultation’ show the highest counts. 
Compared to this, the community-based intermediaries have their highest count on ‘collaboration’. 
There is a tendency that the levels of interaction become more intense when the intermediary- and the 
community-attribute are true. This partly reflects our definition of an online innovation intermediary 
as it requires an ‘explicit enquiry towards the user’ (cf. section 2), i.e. can only be true when the level 
of interaction is consultation, cooperation, or collaboration.  
Stage of innovation process: The dimension “stage of innovation process” describes the time at which 
the users’ input and knowledge can be utilized and integrated into the innovation process. To do so, 
we lean on a linear phase model of the innovation process employed by Diener & Piller (2010). It sug-
gests three major stages: (1) Fuzzy front end, comprising idea generation and evaluation; (2) New 
product development, comprising concept development and prototyping; and (3) Commercialization, 
compromising product test and market launch. Turning to our empirical data, we see the potential that 
the identified innovation intermediaries can support the innovation process – notably at two stages, the 
fuzzy front end (80%) and new product development (20%). 
Community access: Some platform operators provide free access to their community, some others re-
strict the access. Online communities without access restriction trust the mechanism of self-selection 
of members. For reasons of simplicity, we distinguish between restricted and non-restricted access to 
online communities. Interestingly, intermediary platforms restrict user access to specialist communi-
ties to a greater extent than non-intermediary platforms do. We observe this in the relative share of 
restricted access communities of intermediary platforms compared to that of non-intermediary plat-
forms (38% vs. 15%). On the one hand, this is due to the fact that some physician-only platforms in 
this subset require professional certifications during registration process. On the other hand, some oth-
er platforms also ask consumers to apply for membership through explicating their qualification or 
motivation levels.  
5 Discussion 
The previous section has provided us the evidence for five key observations that will be discussed in 
the following. First, innovation intermediaries in health 2.0 are looking for profound experience from 
the healthcare consumer. In particular, they focus on the chronically ill, i.e. patients with a high degree 
of affectedness. Hence, we understand this as a shift away from the generalist consumer experience 
towards a detailed knowledge base on specific disorders. While the focus of many online health com-
munities is on emotional support among peers, the innovation intermediaries discussed here put em-
phasis on a pragmatic exchange of knowledge and potential solutions. 
Second, apart from healthcare consumers only, such intermediaries are interested in a broad and pro-
fessional knowledge base. In general, they are more open to professional involvement and professional 
contributions respectively. In particular, they look beyond medical providers by also targeting suppli-
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ers. Nevertheless, this still means that other key players of the healthcare industry are not involved yet 
(i.e. not involved within the sample investigated). Notably payers (e.g., statutory health insurance, pri-
vate health insurance, and government agencies) and regulators (e.g., ministry of health, national or 
regional committees who set regulatory guidelines) could also act as users and contributors, too. On 
this point, we hypothesise that the perceived benefits of engaging with healthcare consumers through 
the web are still too low for payers and regulators, but might be part of an on-going paradigm shift. 
Third, intermediary platforms engage for more intense interactions with or between their users. Thus, 
knowledge exchange is made easier. And eventually, it can foster the emergence of new ideas and the 
support of innovative activities. The five levels that we discovered within the analysed sample are 
close to existing taxonomies which classify the degree of integration of the public (Boote et al., 2002; 
Arnstein, 1969; Piller et al., 2010). These models confirm the benefits generated by a higher degree of 
integration of and interaction among consumers. In each of the most intense forms of integration, the 
authors proclaim that participants/consumers can enter into partnerships with powerholders or even 
obtain the majority of decision-making. 
Fourth, early stages of the innovation process (i.e. concept development and prototyping) are more 
supported than later stages (i.e. commercialization). However, it remains difficult to systematically 
involve users at the early stages as evidence for such activities is little. Furthermore, health 2.0 users 
seem to be not actively employed during the commercialization stage of novel products (at least, our 
sample did not provide clear evidence for this). 
Fifth, access to specialist communities is more restricted at intermediary platforms. Evidence remains 
low on this point, but we interpret it as a tendency. This observation supports the previous hypothesis 
that operators of intermediary platforms search for particularly suitable and qualified users. By re-
stricting access to their communities, the operator gains more control over the user recruitment pro-
cess. 
6 Limitations and future research 
This study has three main limitations, which in turn has implications for future research. Firstly, the 
identified number of innovation intermediaries in health 2.0 cannot be considered large. We count 30 
of such intermediary platforms in our sample. Hence it may be delicate to draw generalizations from 
our findings. Nonetheless the findings can function as well-grounded directions for future research. 
Secondly, our scope on innovation intermediaries is somewhat limited to a bridging role between the 
healthcare consumers/professionals and medical manufacturing companies. We applied two rather 
simple criteria which qualify an online platform as an innovation intermediary. This pragmatic ap-
proach could be reconsidered and enhanced by other functions (see Howell, 2006 for more).  
Thirdly, we have chosen a desk research approach. That is why the assessment of the dimensions was 
merely done with a blend of publicly available information, i.e. the websites and their self-
descriptions, and third-party reports from Wikipedia to academic articles. Therefore, field research 
about online innovation intermediaries in healthcare may produce a higher level of understanding re-
garding their motivation, function, processes and relationships. In particular, it would be useful to ex-
plore the types of knowledge created by users on the platform (also claimed by Verona et al., 2006) 
and, subsequently, how the platform operators add value to the intermediation process by e.g. repack-
aging or refining the knowledge artefacts. Interviews with such intermediaries would confirm or re-
voke our assessment. Particular insight could come from health 2.0 intermediaries that failed (also 
raised by Hossain, 2012).  
Furthermore, studies on the perceived strengths, weaknesses, requirements, and needs by health 2.0 
users and by research and development departments of medical manufacturers (as potential clients and 
beneficiaries of such innovation intermediaries) can be a fruitful approach to further knowledge in this 
field. Eventually, we rather looked at the user-intermediary interface instead of the manufacturer-
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intermediary interface. It is due to the user-oriented definition of health 2.0 that we have applied 
straight from the start. Hence, for the subset of health 2.0 platforms that qualify as online innovation 
intermediaries, it is advisable to strengthen the understanding of the interface between such intermedi-
aries and medical manufacturers. Another area for future research could be the search for successful 
business models between medical manufacturers and online innovation intermediaries. 
7 Conclusion 
We began this paper by referring to the serious challenges in healthcare and the emerging need for 
innovation in this area. We focused on one of the new avenues along which the engagement of 
healthcare consumers and healthcare professionals might take place – the growing use of interactive 
online platforms in the healthcare sector. Hence our research question aimed at identifying health 2.0 
platforms that can serve as intermediaries in the innovation process. This paper contributes to an an-
swer in a threefold way. 
First, it enhances the academic discussion by creating - for the first time according to our humble 
knowledge – a link between the domains of interactive online health platforms and open innovation. It 
thus puts emphasis on the role of such platforms as advocates of innovation and supporters of the in-
novation process. We used the term ‘online innovation intermediary’.  
Second, it suggests an essential classification and description of the variety of health 2.0 platforms. 
Instead of structuring along technical features of online platforms (which are usually easy to observe 
and to count), the proposed classification scheme scrutinizes the purpose for which each platform is 
run. We started out by proposing an initial typology to differentiate health 2.0 platforms. The suggest-
ed classification scheme distinguishes along two axes: (i) health 2.0 platforms that mediate between 
innovating companies and external stakeholders, and those who do not; as well as (ii) community 
based and non-community based health 2.0 platforms. Based on case vignettes, we found further di-
mensions for classification which are: involvement of healthcare consumers, involvement of profes-
sional stakeholders in healthcare, level of interaction attained by users, the supported stage of innova-
tion process, and the access to online community (cf. table 1). 
Third, it provides a state-of the-art review of web 2.0 platforms in healthcare with an international 
scope that does not restrict to consumer services only, but also includes services for doctors and other 
professional stakeholders. With the examples given in this paper and in the case repository that is 
available online, we are able to sketch a preliminary picture of the market for online innovation inter-
mediaries in healthcare. Based on this, it gives practitioners from corporate environments the neces-
sary orientation when it comes to the decision whether to start their own innovation communities or to 
engage with existing actors in the field. 
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